Biovail Laboratories, Inc. v. Anchen Pharmaceuticals, Inc.

313 F. App'x 306
CourtCourt of Appeals for the Federal Circuit
DecidedJune 11, 2008
DocketNo. 2006-1641
StatusPublished

This text of 313 F. App'x 306 (Biovail Laboratories, Inc. v. Anchen Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Biovail Laboratories, Inc. v. Anchen Pharmaceuticals, Inc., 313 F. App'x 306 (Fed. Cir. 2008).

Opinion

ON MOTION

ORDER

Biovail Laboratories, Inc. moves without opposition to withdraw its notice of appeal pursuant to Fed. R.App. P. 42(b).

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion is granted.

(2) Each side shall bear its own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
313 F. App'x 306, Counsel Stack Legal Research, https://law.counselstack.com/opinion/biovail-laboratories-inc-v-anchen-pharmaceuticals-inc-cafc-2008.